• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

激活素A在进行性骨化性纤维发育不良中的作用:一种重要的介质。

The role of Activin A in fibrodysplasia ossificans progressiva: a prominent mediator.

作者信息

Lin Hui, Shi Fuli, Gao Jiayu, Hua Ping

机构信息

Jiangxi Province Key Laboratory of Tumor Pathogens and Molecular Pathology and Department of Pathophysiology, School of Basic Medicine Sciences, Nanchang University Medical College, Nanchang, China

Jiangxi Province Key Laboratory of Tumor Pathogens and Molecular Pathology and Department of Pathophysiology, School of Basic Medicine Sciences, Nanchang University Medical College, Nanchang, China.

出版信息

Biosci Rep. 2019 Aug 2;39(8). doi: 10.1042/BSR20190377. Print 2019 Aug 30.

DOI:10.1042/BSR20190377
PMID:31341010
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6680371/
Abstract

Heterotopic ossification (HO) is the aberrant formation of mature, lamellar bone in nonosseous tissue. Fibrodysplasia ossificans progressiva (FOP) is a rare and devastating genetic disorder that causes progressive HO in the ligaments, tendons, and muscles throughout the body. FOP is attributed to an autosomal mutation in activin receptor-like kinase 2 (ALK2), a bone morphogenetic protein (BMP) type I receptor. Initial studies show that mutant ALK2 drives HO by constitutively activating the BMP signaling pathway. Recently, mutant ALK2 has been shown to transduce Smad1/5 signaling and enhance chondrogenesis, calcification in response to Activin A, which normally signals through Smad2/3 and inhibits BMP signaling pathway. Furthermore, Activin A induces heterotopic bone formation via mutant ALK2, while inhibition of Activin A blocks spontaneous and trauma-induced HO. In this manuscript, we describe the molecular mechanism of the causative gene in FOP, mainly focusing on the prominent role of Activin A in HO. It reveals a potential strategy for prevention and treatment of FOP by inhibition of Activin A. Further studies are needed to explore the cellular and molecular mechanisms of Activin A in FOP in more detail.

摘要

异位骨化(HO)是指在非骨组织中异常形成成熟的板层骨。进行性骨化性纤维发育不良(FOP)是一种罕见且严重的遗传性疾病,可导致全身韧带、肌腱和肌肉中出现进行性HO。FOP归因于激活素受体样激酶2(ALK2)的常染色体突变,ALK2是一种骨形态发生蛋白(BMP)I型受体。初步研究表明,突变型ALK2通过持续激活BMP信号通路来驱动HO。最近研究发现,突变型ALK2可转导Smad1/5信号,并增强软骨生成、响应激活素A时的钙化,激活素A通常通过Smad2/3信号传导并抑制BMP信号通路。此外,激活素A通过突变型ALK2诱导异位骨形成,而抑制激活素A可阻断自发性和创伤性HO。在本论文中,我们描述了FOP致病基因的分子机制,主要聚焦于激活素A在HO中的突出作用。它揭示了通过抑制激活素A预防和治疗FOP的潜在策略。需要进一步研究以更详细地探索激活素A在FOP中的细胞和分子机制。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/26f3/6680371/0e346c1322d7/bsr-39-bsr20190377-g3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/26f3/6680371/10fa2c9f4eae/bsr-39-bsr20190377-g1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/26f3/6680371/8dedd9791dd2/bsr-39-bsr20190377-g2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/26f3/6680371/0e346c1322d7/bsr-39-bsr20190377-g3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/26f3/6680371/10fa2c9f4eae/bsr-39-bsr20190377-g1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/26f3/6680371/8dedd9791dd2/bsr-39-bsr20190377-g2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/26f3/6680371/0e346c1322d7/bsr-39-bsr20190377-g3.jpg

相似文献

1
The role of Activin A in fibrodysplasia ossificans progressiva: a prominent mediator.激活素A在进行性骨化性纤维发育不良中的作用:一种重要的介质。
Biosci Rep. 2019 Aug 2;39(8). doi: 10.1042/BSR20190377. Print 2019 Aug 30.
2
The obligatory role of Activin A in the formation of heterotopic bone in Fibrodysplasia Ossificans Progressiva.在进行性骨化性纤维发育不良中,激活素 A 在异位骨形成中的必然作用。
Bone. 2018 Apr;109:210-217. doi: 10.1016/j.bone.2017.06.011. Epub 2017 Jun 16.
3
[Fibrodysplasia ossificans progressiva and osteoimmunology].[进行性骨化性纤维发育不良与骨免疫学]
Clin Calcium. 2016 May;26(5):691-8.
4
The ACVR1 R206H mutation found in fibrodysplasia ossificans progressiva increases human induced pluripotent stem cell-derived endothelial cell formation and collagen production through BMP-mediated SMAD1/5/8 signaling.在进行性骨化性纤维发育不良中发现的ACVR1 R206H突变通过BMP介导的SMAD1/5/8信号通路增加人诱导多能干细胞衍生的内皮细胞形成和胶原蛋白生成。
Stem Cell Res Ther. 2016 Aug 17;7(1):115. doi: 10.1186/s13287-016-0372-6.
5
Recent progress in drug development for fibrodysplasia ossificans progressiva.成纤维细胞性骨化性纤维发育不良药物治疗的最新进展。
Mol Cell Biochem. 2022 Oct;477(10):2327-2334. doi: 10.1007/s11010-022-04446-9. Epub 2022 May 10.
6
Overexpression of Wild-Type ACVR1 in Fibrodysplasia Ossificans Progressiva Mice Rescues Perinatal Lethality and Inhibits Heterotopic Ossification.野生型 ACVR1 在进行性骨化性纤维发育不良小鼠中的过表达可挽救围产期致死性并抑制异位骨化。
J Bone Miner Res. 2022 Nov;37(11):2077-2093. doi: 10.1002/jbmr.4617. Epub 2022 Jul 3.
7
Alk2 regulates early chondrogenic fate in fibrodysplasia ossificans progressiva heterotopic endochondral ossification.激活素受体样激酶2(Alk2)在进行性骨化性纤维发育不良的异位软骨内骨化过程中调节早期软骨形成命运。
Stem Cells. 2014 May;32(5):1289-300. doi: 10.1002/stem.1633.
8
Activin A amplifies dysregulated BMP signaling and induces chondro-osseous differentiation of primary connective tissue progenitor cells in patients with fibrodysplasia ossificans progressiva (FOP).激活素 A 放大失调的 BMP 信号,并诱导进行性骨化性纤维发育不良(FOP)患者的原始结缔组织祖细胞向软骨骨分化。
Bone. 2018 Apr;109:218-224. doi: 10.1016/j.bone.2017.11.014. Epub 2017 Nov 21.
9
ALK2 R206H mutation linked to fibrodysplasia ossificans progressiva confers constitutive activity to the BMP type I receptor and sensitizes mesenchymal cells to BMP-induced osteoblast differentiation and bone formation.ALK2 R206H 突变与进行性骨化性纤维发育不良相关,赋予 BMP Ⅰ型受体组成型活性,并使间充质细胞对 BMP 诱导的成骨细胞分化和骨形成敏感。
J Bone Miner Res. 2010 Jun;25(6):1208-15. doi: 10.1359/jbmr.091110.
10
Spatial patterns of heterotopic ossification in fibrodysplasia ossificans progressiva correlate with anatomic temperature gradients.纤维性骨发育不良性骨化症中的异位骨化的空间模式与解剖学温度梯度相关。
Bone. 2021 Aug;149:115978. doi: 10.1016/j.bone.2021.115978. Epub 2021 Apr 27.

引用本文的文献

1
Role of hedgehog signaling in the pathogenesis and therapy of heterotopic ossification.刺猬信号通路在异位骨化的发病机制及治疗中的作用
Front Cell Dev Biol. 2024 Sep 19;12:1454058. doi: 10.3389/fcell.2024.1454058. eCollection 2024.
2
How Activin A Became a Therapeutic Target in Fibrodysplasia Ossificans Progressiva.激活素 A 如何成为进行性骨化性纤维发育不良的治疗靶点。
Biomolecules. 2024 Jan 12;14(1):101. doi: 10.3390/biom14010101.
3
Pathophysiology and Emerging Molecular Therapeutic Targets in Heterotopic Ossification.异位骨化的病理生理学和新兴分子治疗靶点。

本文引用的文献

1
The effect of Activin-A on periodontal ligament fibroblasts-mediated osteoclast formation in healthy donors and in patients with fibrodysplasia ossificans progressiva.激活素 A 对健康供体和进行性骨化性纤维发育不良患者牙周膜成纤维细胞介导的破骨细胞形成的影响。
J Cell Physiol. 2019 Jul;234(7):10238-10247. doi: 10.1002/jcp.27693. Epub 2018 Nov 11.
2
An mTOR Signaling Modulator Suppressed Heterotopic Ossification of Fibrodysplasia Ossificans Progressiva.一种 mTOR 信号调节剂抑制纤维发育不良性骨化性纤维发育不良的异位骨化。
Stem Cell Reports. 2018 Nov 13;11(5):1106-1119. doi: 10.1016/j.stemcr.2018.10.007. Epub 2018 Nov 1.
3
Int J Mol Sci. 2022 Jun 23;23(13):6983. doi: 10.3390/ijms23136983.
4
Palovarotene Can Attenuate Heterotopic Ossification Induced by Tendon Stem Cells by Downregulating the Synergistic Effects of Smad and NF-B Signaling Pathway following Stimulation of the Inflammatory Microenvironment.帕罗维罗汀可通过下调炎症微环境刺激后Smad和NF-κB信号通路的协同作用来减轻肌腱干细胞诱导的异位骨化。
Stem Cells Int. 2022 Apr 28;2022:1560943. doi: 10.1155/2022/1560943. eCollection 2022.
5
Fibrodysplasia Ossificans Progressiva: What Have We Achieved and Where Are We Now? Follow-up to the 2015 Lorentz Workshop.骨化性纤维发育不良进展性:我们已经取得了哪些成就,现在又在哪里?对 2015 年洛伦茨研讨会的跟进。
Front Endocrinol (Lausanne). 2021 Nov 10;12:732728. doi: 10.3389/fendo.2021.732728. eCollection 2021.
6
Contributions of the Endothelium to Vascular Calcification.内皮细胞对血管钙化的作用。
Front Cell Dev Biol. 2021 May 17;9:620882. doi: 10.3389/fcell.2021.620882. eCollection 2021.
7
Role of Signal Transduction Pathways and Transcription Factors in Cartilage and Joint Diseases.信号转导通路和转录因子在软骨和关节疾病中的作用。
Int J Mol Sci. 2020 Feb 17;21(4):1340. doi: 10.3390/ijms21041340.
ACVR1 FOP mutation alters mechanosensing and tissue stiffness during heterotopic ossification.
ACVR1 FOP 突变改变异位骨化过程中的机械感知和组织硬度。
Mol Biol Cell. 2019 Jan 1;30(1):17-29. doi: 10.1091/mbc.E18-05-0311. Epub 2018 Oct 31.
4
The Horizon of a Therapy for Rare Genetic Diseases: A "Druggable" Future for Fibrodysplasia Ossificans Progressiva.罕见遗传性疾病治疗的新曙光:成骨不全性骨纤维发育异常的“可成药”未来。
Int J Mol Sci. 2018 Mar 26;19(4):989. doi: 10.3390/ijms19040989.
5
Inhibition of overactive TGF-β attenuates progression of heterotopic ossification in mice.抑制过度活跃的 TGF-β 可减轻小鼠异位骨化的进展。
Nat Commun. 2018 Feb 7;9(1):551. doi: 10.1038/s41467-018-02988-5.
6
Activin-dependent signaling in fibro/adipogenic progenitors causes fibrodysplasia ossificans progressiva.激活素依赖性信号在纤维/脂肪祖细胞中引起进行性骨化性纤维发育不良。
Nat Commun. 2018 Feb 2;9(1):471. doi: 10.1038/s41467-018-02872-2.
7
Acute and chronic rapamycin use in patients with Fibrodysplasia Ossificans Progressiva: A report of two cases.成骨不全性骨形成不全进展期患者中急性和慢性雷帕霉素的应用:两例报告。
Bone. 2018 Apr;109:281-284. doi: 10.1016/j.bone.2017.12.011. Epub 2017 Dec 11.
8
Hard targets for a second skeleton: therapeutic horizons for fibrodysplasia ossificans progressiva (FOP).针对第二副骨骼的艰巨目标:进行性骨化性纤维发育不良(FOP)的治疗前景。
Expert Opin Orphan Drugs. 2017;5(4):291-294. doi: 10.1080/21678707.2017.1304211. Epub 2017 Mar 17.
9
Activin A amplifies dysregulated BMP signaling and induces chondro-osseous differentiation of primary connective tissue progenitor cells in patients with fibrodysplasia ossificans progressiva (FOP).激活素 A 放大失调的 BMP 信号,并诱导进行性骨化性纤维发育不良(FOP)患者的原始结缔组织祖细胞向软骨骨分化。
Bone. 2018 Apr;109:218-224. doi: 10.1016/j.bone.2017.11.014. Epub 2017 Nov 21.
10
Variable signaling activity by FOP ACVR1 mutations.FOP ACVR1 突变的可变信号活性。
Bone. 2018 Apr;109:232-240. doi: 10.1016/j.bone.2017.10.027. Epub 2017 Oct 31.